Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Afidah A-Manaf
Capecitabine and Oxaliplatin (XELOX) Is Safe and Effective in Patients With Advanced Gastric Cancer
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Related publications
2318 Prospective Phase II Trial of Pazopanib Plus CapeOX (Capecitabine and Oxaliplatin) in Previously Untreated Patients With Advanced Gastric Cancer
European Journal of Cancer
Cancer Research
Oncology
A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
S-1 With Leucovorin and Oxaliplatin for Advanced Gastric Cancer
The Lancet Oncology
Oncology
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome
Clinical Colorectal Cancer
Oncology
Gastroenterology
A Multi-Center Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Mp02-08 Holep in Patients With Low Risk Prostate Cancer Is Safe and Effective
Journal of Urology
Urology
Capecitabine and Oxaliplatin Versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients With Locally Advanced Rectal Carcinoma: A Comparative Study
Journal of Cancer Therapy
Should S-1 Be Better Than Capecitabine for Patients With Advanced Gastric Cancer in Asia? A Systematic Review and Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Is "Safe Effective Glucose Control" Effective and Safe?
Critical Care
Critical Care
Intensive Care Medicine
